Form4insider filings, from the source

SEC Form 4 · accession 0001209191-17-011768

Atara Biotherapeutics, Inc. · ATRA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
John McGrath
Officer — EVP & Chief Financial Officer
Period of report
Feb 15, 2017
Accepted (ET)
Feb 16, 2017 · 8:11 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001604464

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Feb 15, 2017M2,804$0.00A152,130D
Common StockF1Feb 15, 2017M7,697$0.00A159,827D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitsF5,F2,F3,F4—Feb 15, 2017M2,804D——Common Stock2,804935I
Restricted Stock UnitsF5,F2,F6,F7—Feb 15, 2017M7,697D——Common Stock7,69728,224I

Explanation of responses